Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Celldex Therapeutics Inc.

www.celldextherapeutics.com

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Alias(es)
  • Virus Research Institute Inc.
  • T Cell Sciences
  • Avant Immunotherapeutics Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Celldex Therapeutics Inc.
  • Senior Management
  • Anthony S Marucci, Pres. & CEO
    Avery W Catlin, SVP, CFO
    Tibor Keler, PhD, EVP, CSO
    Ronald A Pepin, PhD, SVP, CBO
    Richard Wright, Chief Commercial Officer
    Elizabeth Crowley, Chief Product Dev. Officer
    Theresa LaVallee, PhD, SVP, Regulatory & Precision Medicine
  • Contact Info
  • Celldex Therapeutics Inc.
    Phone: (908) 454-7120
    53 Frontage Rd.
    Ste. 220
    Hampton, NJ 08827
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register